# Beijing Medical and Health Industry Investment Fund

> Beijing Medical and Health Industry Investment Fund is a VC fund backing Biotechnology. See 34 investments, check sizes, portfolio and contact details…

- Type: VC Fund
- Total investments: 34
- Last investment: Jul 2026
- Lead investor: 53%
- Last updated: Aug 2026
- Website: https://kw.beijing.gov.cn/art/2024/3/25/art_1140_674248.html

Beijing Medical and Health Industry Investment Fund is a VC fund focused on Biotechnology and Medical. Beijing Medical and Health Industry Investment Fund provides investments.

## Contacts

5 contacts available for Beijing Medical and Health Industry Investment Fund. Shizune tracks 1 team members at Beijing Medical and Health Industry Investment Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/beijing-medical-and-health-industry-investment-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 13 | 38% |
| Medical | 12 | 35% |
| Health Care | 12 | 35% |
| Pharmaceutical | 9 | 26% |
| Medical Device | 8 | 24% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 11 | 32% |
| Series B | 8 | 24% |
| Venture - Series Unknown | 5 | 15% |
| Series C | 4 | 12% |
| Series D | 3 | 9% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Su Zhiqiang | Managing Director | 1 | https://shizune.co/investors/profile/su-zhiqiang-28e2 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Genta Kyushu Bio | Genta Kyushu Bio is a cutting edge biotechnology company specializing in the development of precision neuro circuit therapies for central nervous system and ophthalmic diseases. The firm leverages its high throughput screening and drug development platforms to advance innovative treatments utilizing chemogenetics, optogenetics, and gene therapies. | $14.8M | Series A | Jul 30, 2026 |  |
| Yanming Biology | Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors. |  | Series B | Jul 03, 2026 |  |
| Qinghui Liannuo | Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the γδ-T cell immunotherapy industry. Committed to bringing good news to patients with refractory andrecurrent solid tumors and hematomas. | $29.5M | Series A | Jun 09, 2026 |  |
| X-MAGTECH | X-MAGTECH is a technology platform for measuring extremely weak magnetic fields. | $14.8M | Series B | Jun 04, 2026 |  |
| Kanova | Kanova is a biopharmaceutical firm. |  | Venture - Series Unknown | Apr 29, 2026 |  |
| Oricell Therapeutics | OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy. | $110M | Venture - Series Unknown | Apr 09, 2026 |  |
| Ace Cardio | Ace Cardio is an ultrasound technology company that offers research and development of ultrasound imaging systems. |  | Series A | Apr 07, 2026 |  |
| TOPI Imaging Technology | TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer. | $57.9M | Venture - Series Unknown | Mar 26, 2026 |  |
| Chromai | Chromai offers high-performance intelligent liquid chromatography and medical diagnostic solutions. The company insists on independent innovation and takes the revitalization of national industry as its own responsibility. |  | Venture - Series Unknown | Feb 24, 2026 |  |
| Daxiang Biotech | Daxiang Biotech develops and produces human organoid chips. It is committed to promoting organoid chips in new drug research and development, disease modeling, and individualization. | $14.5M | Series B | Feb 13, 2026 |  |

10 of 34 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 6 deals together
- [Shunxi Fund](https://shizune.co/investors/profile/shunxi-fund) — VC Fund, 6 deals together
- [Beijing E-town International Investment & Development](https://shizune.co/investors/profile/beiid) — VC Fund, 4 deals together
- [Zhongguancun Capital](https://shizune.co/investors/profile/zhongguancun-capital) — VC Fund, 4 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 3 deals together
- [Frees Fund](https://shizune.co/investors/profile/freesfund) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Beijing Medical and Health Industry Investment Fund invest in?

Beijing Medical and Health Industry Investment Fund invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 34 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Beijing Medical and Health Industry Investment Fund?

Public channels for Beijing Medical and Health Industry Investment Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Beijing Medical and Health Industry Investment Fund?

The team at Beijing Medical and Health Industry Investment Fund includes Su Zhiqiang (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co